Legislators
Bills
Statements
Lobbying
Travel
Searching...- Lobbying
- Lobbying by Varian Medical Systems, Inc.
Lobbying Relationship
Bills mentioned
S.934: FDA Reauthorization Act of 2017
Sponsor: Lamar Alexander (R-Tenn.)
H.R.2430: FDA Reauthorization Act of 2017
Sponsor: Greg Walden (R-Ore.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
| Lobbyist | Covered positions? |
|---|---|
| Cindy Brown | Chief of Staff, Representative Ron Kind |
| Ashley Davis | Special Assistant to the Homeland Security Director, Executive Office of the President; Deputy Director of Management and Administration, Executive Office of the President |
| Malloy McDaniel | Policy Advisor, Senate Minority Leader Mitch McConnell; Whip Liaison, Senate Majority Whip Mitch McConnell; Floor Assistant, Senate Majority Leader Trent Lott; Cloakroom Assistant, Office of the Republican Secretary |
| Kristi Remington | Deputy Assistant Attorney General, US Department of Justice; Senior Counsel, House Government Reform Committee |
| Shimon Stein | Senior Policy Advisor, House Majority Leader Eric Cantor; Program Manager, US Department of Justice; Legislative Correspondent, Senator John Ashcroft; Paid Intern, Represenative Robert Aderholt |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate